Answer
Yes, Alunbrig (brigatinib) can increase sensitivity to sunlight, so patients should avoid prolonged sun exposure during treatment and for at least 5 days after stopping.
Sources for this answer
- Alunbrig 30 mg film-coated tabletsTakeda UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked